Published in J Physiol on March 01, 2002
CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest (2004) 5.36
Anion permeation in human ClC-4 channels. Biophys J (2003) 1.22
Identification of an N-terminal amino acid of the CLC-3 chloride channel critical in phosphorylation-dependent activation of a CaMKII-activated chloride current. J Physiol (2004) 1.17
Channel-like slippage modes in the human anion/proton exchanger ClC-4. J Gen Physiol (2009) 1.14
Conduction mechanisms of chloride ions in ClC-type channels. Biophys J (2004) 1.13
Characterization of a proton-activated, outwardly rectifying anion channel. J Physiol (2005) 1.06
The ClC-3 Cl-/H+ antiporter becomes uncoupled at low extracellular pH. J Biol Chem (2009) 1.01
Nucleotides bind to the C-terminus of ClC-5. Biochem J (2006) 0.94
Biophysical and pharmacological characterization of hypotonically activated chloride currents in cortical astrocytes. Glia (2004) 0.93
ClC transporters: discoveries and challenges in defining the mechanisms underlying function and regulation of ClC-5. Pflugers Arch (2010) 0.87
Insights into the ClC-4 transport mechanism from studies of Zn2+ inhibition. Biophys J (2008) 0.87
Anion- and proton-dependent gating of ClC-4 anion/proton transporter under uncoupling conditions. Biophys J (2011) 0.87
To ATP or not to ATP: this is the question. J Gen Physiol (2008) 0.86
Identification and functional characterization of a voltage-gated chloride channel and its novel splice variant in taste bud cells. J Biol Chem (2005) 0.82
Regulation of ClC-2 gating by intracellular ATP. Pflugers Arch (2013) 0.79
The ClC-3 chloride channel and osmoregulation in the European sea bass, Dicentrarchus labrax. J Comp Physiol B (2013) 0.77
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60
Nucleoside phosphorothioates. Annu Rev Biochem (1985) 7.55
Patch-clamp techniques for time-resolved capacitance measurements in single cells. Pflugers Arch (1988) 4.88
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell (1992) 4.71
Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature (1990) 4.55
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell (2001) 4.36
A common molecular basis for three inherited kidney stone diseases. Nature (1996) 4.26
Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel. Nature (1991) 3.62
Two physically distinct pores in the dimeric ClC-0 chloride channel. Nature (1996) 3.58
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron (2001) 3.51
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet (1997) 3.51
Homodimeric architecture of a ClC-type chloride ion channel. Nature (1996) 3.47
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature (2000) 2.79
Molecular identification of a volume-regulated chloride channel. Nature (1997) 2.48
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A (1998) 2.34
Heteromultimeric CLC chloride channels with novel properties. Proc Natl Acad Sci U S A (1996) 2.28
Multimeric structure of ClC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen). EMBO J (1994) 2.08
Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. J Biol Chem (1995) 2.00
Chloride channels activated by osmotic stress in T lymphocytes. J Gen Physiol (1993) 1.99
The CLC chloride channel family. Pflugers Arch (1999) 1.95
Hyperpolarization-activated chloride currents in Xenopus oocytes. J Gen Physiol (1994) 1.80
Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. J Biol Chem (1999) 1.78
Intracellular Ca2+ and Cl- channel activation in secretory cells. Annu Rev Physiol (2000) 1.55
Human astrocytoma cells express a unique chloride current. Neuroreport (1996) 1.50
Subunit stoichiometry of human muscle chloride channels. J Gen Physiol (1997) 1.47
A gene from the Xp22.3 region shares homology with voltage-gated chloride channels. Hum Mol Genet (1994) 1.40
Molecular cloning and characterization of p64, a chloride channel protein from kidney microsomes. J Biol Chem (1993) 1.28
Expression of human pICln and ClC-6 in Xenopus oocytes induces an identical endogenous chloride conductance. J Biol Chem (1997) 1.24
The 'ABC' of GABA receptors: a brief review. Clin Exp Pharmacol Physiol (1999) 1.23
Biophysical properties of ClC-3 differentiate it from swelling-activated chloride channels in Chinese hamster ovary-K1 cells. J Biol Chem (2000) 1.19
Cell swelling activates ATP-dependent voltage-gated chloride channels in M-1 mouse cortical collecting duct cells. J Gen Physiol (1996) 1.11
Separate swelling- and Ca2+-activated anion currents in Ehrlich ascites tumor cells. J Membr Biol (1998) 1.07
Expression of CLCN voltage-gated chloride channel genes in human blood vessels. J Mol Cell Cardiol (1999) 1.02
Identification of a new outwardly rectifying Cl- channel that belongs to a subfamily of the ClC Cl- channels. J Biol Chem (1996) 0.96
Characterization of chloride currents and their noradrenergic modulation in rat taste receptor cells. J Neurophysiol (1999) 0.93
Effects of barium, lanthanum and gadolinium on endogenous chloride and potassium currents in Xenopus oocytes. J Physiol (1996) 0.91
The volume-activated chloride current in human endothelial cells depends on intracellular ATP. Pflugers Arch (1994) 0.91
ATP is not required for anion current activated by cell swelling in multidrug-resistant lung cancer cells. Am J Physiol (1994) 0.91
Cloning and functional expression of a ClC Cl- channel from the renal cell line A6. Am J Physiol (1997) 0.87
Identification of an acid-activated Cl(-) channel from human skeletal muscles. Am J Physiol (1999) 0.86
P-glycoprotein is not a swelling-activated Cl- channel; possible role as a Cl- channel regulator. J Physiol (1997) 0.86
Role of the cytoskeleton in the regulation of Cl- channels in human embryonic skeletal muscle cells. Pflugers Arch (1994) 0.84
Glycine receptors: what gets in and why? Clin Exp Pharmacol Physiol (1999) 0.83
Dual role of ATP in supporting volume-regulated chloride channels in mouse fibroblasts. Biochim Biophys Acta (2000) 0.80
How to lose your hippocampus by working on chloride channels. Neuron (2001) 0.79
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation (2007) 4.10
PiggyBac transposon-mediated gene transfer in human cells. Mol Ther (2007) 4.07
Molecular basis of an inherited epilepsy. Neuron (2002) 3.77
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation (2002) 2.98
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation (2005) 2.78
Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation (2013) 2.66
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis (2005) 2.43
Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol (2013) 2.30
Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation (2007) 2.28
Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel. Biochemistry (2008) 2.22
Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J Am Soc Nephrol (2008) 2.04
Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics (2003) 2.03
Long QT syndrome-associated mutations in intrauterine fetal death. JAMA (2013) 2.00
NOS1AP is a genetic modifier of the long-QT syndrome. Circulation (2009) 2.00
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J Am Coll Cardiol (2008) 1.91
Cardiac ion channels. Annu Rev Physiol (2002) 1.90
Myotonia congenita. Adv Genet (2008) 1.80
Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J Neurosci (2003) 1.77
Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation (2005) 1.77
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks). J Mol Cell Cardiol (2005) 1.70
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm (2004) 1.68
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation (2002) 1.65
Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci U S A (2004) 1.65
KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet (2002) 1.60
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm (2008) 1.59
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J Am Coll Cardiol (2012) 1.58
Multiplexed transposon-mediated stable gene transfer in human cells. Proc Natl Acad Sci U S A (2010) 1.57
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ Arrhythm Electrophysiol (2008) 1.53
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet (2002) 1.51
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation (2005) 1.48
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation (2011) 1.38
Structural models for the KCNQ1 voltage-gated potassium channel. Biochemistry (2007) 1.38
Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry (2007) 1.35
Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibition. FEBS Lett (2005) 1.35
The genetic basis of variability in drug responses. Nat Rev Drug Discov (2002) 1.34
Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption. Hum Hered (2007) 1.30
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet (2014) 1.27
Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants. Circ Res (2014) 1.27
Improved DNA sequencing quality and efficiency using an optimized fast cycle sequencing protocol. Biotechniques (2007) 1.26
Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int (2004) 1.24
Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. Brain Res Mol Brain Res (2002) 1.24
Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet (2013) 1.23
Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res (2007) 1.23
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity. Clin Infect Dis (2006) 1.18
Strategy for encoding and comparison of gene expression signatures. Genome Biol (2007) 1.18
Genetic variation in the rhythmonome: ethnic variation and haplotype structure in candidate genes for arrhythmias. Pharmacogenomics (2009) 1.16
Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol (2012) 1.15
Single-channel properties of human NaV1.1 and mechanism of channel dysfunction in SCN1A-associated epilepsy. J Gen Physiol (2006) 1.14
Divergent sodium channel defects in familial hemiplegic migraine. Proc Natl Acad Sci U S A (2008) 1.13
Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures. J Physiol (2005) 1.12
Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther (2011) 1.12
Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia. Heart Rhythm (2011) 1.11
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties. Proc Natl Acad Sci U S A (2006) 1.11
Coupled analysis of gene expression and chromosomal location. Genomics (2005) 1.10
KCNE4 can co-associate with the I(Ks) (KCNQ1-KCNE1) channel complex. FEBS J (2008) 1.10
Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives. Heart Rhythm (2005) 1.10
Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures. Epilepsia (2008) 1.09
Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J Clin Invest (2002) 1.07
In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia. Proc Natl Acad Sci U S A (2004) 1.07
Nav 1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome. Eur J Neurosci (2011) 1.07
Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy. Epilepsia (2006) 1.07
Impaired inactivation gate stabilization predicts increased persistent current for an epilepsy-associated SCN1A mutation. J Neurosci (2006) 1.06
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain (2002) 1.06
SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs. Epilepsia (2011) 1.06
Molecular physiology of renal ClC chloride channels/transporters. Curr Opin Nephrol Hypertens (2006) 1.04
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One (2013) 1.04
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. Circ Cardiovasc Genet (2013) 1.03
Expression and transcriptional control of human KCNE genes. Genomics (2005) 1.03
Propranolol blocks cardiac and neuronal voltage-gated sodium channels. Front Pharmacol (2010) 1.03
Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block. J Physiol (2003) 1.02
Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility. Proc Natl Acad Sci U S A (2011) 1.02
Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations. Br J Pharmacol (2010) 1.00
Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation (2003) 0.97
Cardiac potassium channel dysfunction in sudden infant death syndrome. J Mol Cell Cardiol (2007) 0.96
Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome. J Cardiovasc Pharmacol (2012) 0.95
The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. FASEB J (2003) 0.95
Transcriptional networks in epithelial-mesenchymal transition. PLoS One (2011) 0.95
Extracellular sodium interacts with the HERG channel at an outer pore site. J Gen Physiol (2002) 0.95
Web-based interrogation of gene expression signatures using EXALT. BMC Bioinformatics (2009) 0.94
High-resolution mapping of the sodium channel modifier Scnm1 on mouse chromosome 3 and identification of a 1.3-kb recombination hot spot. Genomics (2003) 0.94
SCN5A variation is associated with electrocardiographic traits in the Jackson Heart Study. Circ Cardiovasc Genet (2011) 0.93
The KATP channel is a molecular sensor of atrophy in skeletal muscle. J Physiol (2010) 0.93
Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome. Hum Mutat (2006) 0.92
Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol (2002) 0.92
Antiepileptic activity of preferential inhibitors of persistent sodium current. Epilepsia (2014) 0.91
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats. Neuromuscul Disord (2007) 0.90
KCNE4 juxtamembrane region is required for interaction with calmodulin and for functional suppression of KCNQ1. J Biol Chem (2010) 0.90
Mechanism of sodium channel NaV1.9 potentiation by G-protein signaling. J Gen Physiol (2013) 0.90
Functional BSND variants in essential hypertension. Am J Hypertens (2007) 0.89
Distinct subdomains of the KCNQ1 S6 segment determine channel modulation by different KCNE subunits. J Gen Physiol (2009) 0.87
Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome. Channels (Austin) (2007) 0.86
Activation of protein kinase C alters the intracellular distribution and mobility of cardiac Na+ channels. Am J Physiol Heart Circ Physiol (2011) 0.86
Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease. J Am Soc Nephrol (2011) 0.86
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. Exp Neurol (2013) 0.86
KCNE4 domains required for inhibition of KCNQ1. J Physiol (2008) 0.85